Recruiting studies: Hereditary Angioedema Type 1

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of IV Human Plasma-derived C1 Esterase Inhibitor Concentrate in Patients With Congenital C1-INH Deficiency for Tre
Phase 3 · 23 location(s) · Octapharma · NCT06361537 STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Phase 3 · 51 location(s) · ADARx Pharmaceuticals, Inc. · NCT06960213 Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in
Phase 3 · 62 location(s) · Pharvaris Netherlands B.V. · NCT06679881 A Study to Learn About the C1-Inhibitor Function as Diagnosis for Hereditary Angioedema
NA · 1 location(s) · Takeda · NCT07293364 A Study of Lanadelumab in Teenagers and Adults With Hereditary Angioedema (HAE) in the Kingdom of Saudi Arabia
Phase N/A · 1 location(s) · Takeda · NCT07263685 A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Hereditary Angioedema (HAE)
Phase N/A · 22 location(s) · CSL Behring · NCT07001280 Oral Deucrictibant for Prophylactic and Acute Treatment in Hereditary Angioedema Patients
Phase 1/Phase 2 · 1 location(s) · Institute for Asthma and Allergy · NCT07046806 Donidalorsen Treatment in Children With Hereditary Angioedema
Phase 3 · 10 location(s) · Ionis Pharmaceuticals, Inc. · NCT07298447 Real-life Ecological Momentary Assessment of Lived Burden in Hereditary AngioEdema
Phase N/A · 1 location(s) · Istituti Clinici Scientifici Maugeri SpA · NCT07448181 Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)
Phase 3 · 48 location(s) · ADARx Pharmaceuticals, Inc. · NCT07428499 Institutional Registry of Rare Diseases
Phase N/A · 1 location(s) · Hospital Italiano de Buenos Aires · NCT06573723

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.